ARTICLE | Company News
Isis deal
January 11, 1993 8:00 AM UTC
Isis Pharmaceuticals Inc. INC Eisai Co. Ltd. has exercised an option to license from ISIP an antisense oligonucleotide analog against cytomegalovirus (CMV) infections. Under the terms of a 1990 res...